Top

Journal of Neurology

Published in:

01-02-2011 | Letter to the Editors

Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour

Authors: A. Häne, M. Bargetzi, E. Hewer, M. Bruehlmeier, A. Khamis, U. Roelcke

Published in: Journal of Neurology | Issue 2/2011

Excerpt

Dear Sirs, …

Lucchinetti CF, Gavrilova RH, Metz I et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131:1759–1775CrossRefPubMed

Ng S, Butzkueven H, Kalnins R et al (2007) Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci 14:1126–1129CrossRefPubMed

Kim DS, Na DG, Kim KH et al (2009) Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Radiology 251:467–475CrossRefPubMed

Jain R, Ellika S, Lehmann NL et al (2010) Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol 97:383–388CrossRefPubMed

Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18–27CrossRefPubMed

Sloand EM, Rezvani K (2008) The role of the immune system in myelodysplasia: implications for therapy. Semin Hematol 45:39–48CrossRefPubMed

Derweesh IH, Tannenbaum CS, Rayman PA et al (2003) Mechanisms of immune dysfunction in renal cell carcinoma. Cancer Treat Res 116:29–51PubMed

Xia L, Lin S, Wang ZC et al (2009) Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev 32:171–179CrossRefPubMed

Nadkar MY, Deore RA, Singh R (2008) Tumefactive demyelination. J Assoc Physicians India 56:901–903PubMed

10.

Mao-Draayer Y, Braff S, Pendlebury W et al (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074–1077CrossRefPubMed

Title: Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour
Authors: A. Häne
M. Bargetzi
E. Hewer
M. Bruehlmeier
A. Khamis
U. Roelcke
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 2/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5722-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2011

Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study

Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis

Autoimmune encephalopathy presenting as a ‘posterior circulation stroke’

A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot–Marie–Tooth disease

Gene therapy: a viable therapeutic strategy for Parkinson’s disease?

Disabling Parkinsonism following brief exposure to lithium carbonate in amyotrophic lateral sclerosis